These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23096939)
1. Population pharmacokinetics of digoxin in elderly patients. Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939 [TBL] [Abstract][Full Text] [Related]
2. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients. Choi SA; Yun HY; Lee ES; Shin WG Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants. Gong Y; Chen Y; Li Q; Li Z J Pharmacol Sci; 2014; 125(2):142-9. PubMed ID: 24837877 [TBL] [Abstract][Full Text] [Related]
5. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310 [TBL] [Abstract][Full Text] [Related]
6. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic investigation of digoxin in Japanese neonates. Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients. Jiao Z; Shi XJ; Li ZD; Zhong MK Br J Clin Pharmacol; 2009 Jul; 68(1):47-60. PubMed ID: 19660003 [TBL] [Abstract][Full Text] [Related]
9. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic investigation of digoxin in Japanese infants and young children. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416 [TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetic Studies of Digoxin in Adult Patients: A Systematic Review. Abdel Jalil M; Abdullah N; Alsous M; Abu-Hammour K Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):325-342. PubMed ID: 33616855 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. EL Desoky ES; Nagaraja NV; Derendorf H Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506 [TBL] [Abstract][Full Text] [Related]
13. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of levosimendan in patients with congestive heart failure. Jonsson EN; Antila S; McFadyen L; Lehtonen L; Karlsson MO Br J Clin Pharmacol; 2003 Jun; 55(6):544-51. PubMed ID: 12814448 [TBL] [Abstract][Full Text] [Related]
15. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency. Du P; Wang A; Ma Y; Jia A; Li Y; Li X Clin Ther; 2020 Sep; 42(9):1799-1810.e3. PubMed ID: 32798059 [TBL] [Abstract][Full Text] [Related]
16. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure. Carlton LD; Patterson JH; Mattson CN; Schmith VD J Clin Pharmacol; 1996 Mar; 36(3):247-56. PubMed ID: 8690819 [TBL] [Abstract][Full Text] [Related]
17. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of digoxin in Thai pediatric patients. Preechagoon Y; Somsaard P; Petcharattana S J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Zhou XD; Gao Y; Guan Z; Li ZD; Li J Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]